The Food and Drug Administration issued a warning in June 2011 that diabetic patients who have taken Actos and other pioglitazone-containing medicines are at a higher risk of developing bladder cancer. The warning notes that the risk is higher in patients who have taken higher dosages of Actos for more than 12 months.
France has stopped the release of these drugs. The FDA noted that it was aware of France’s decision. However, the FDA has not banned these medicines from being issued in the United States.
Gersowitz Libo & Korek, P.C. has been researching patients who have developed bladder cancer as a result of taking Actos and is now accepting new clients. If you or a loved one has fallen victim to the drug Actos, contact Gersowitz Libo & Korek, P.C. at (800) 529-9997 to learn your legal rights.
NYPD Searching For Driver Involved in Livery Cab Collision That Left One Person Dead and…
Girl Remains Hospitalized After 15-Year-Old Girl Died in East Village, Manhattan Truck Accident EAST VILLAGE,…
Suffolk County Police Investigating Serious Injury Motorcycle Collision on Little East Neck Road WEST BABYLON,…
Driver Charged Following Fatal Collision in Astoria That Killed Young Woman ASTORIA, QUEENS (October 9,…
We are proud to congratulate Jeff Korek on being recognized by Doyle’s Guide as one…
One Teen Listed in Critical Condition After Tractor Pulling Hayride Overturns in Wellsburg WELLSBURG, NEW…